Abstract-The main goals of general anesthesia are adequate hypnosis, analgesia and maintenance of vital functions. For some special kinds of operations neuromuscular block is essential.
I. INTRODUCTION AND MOTIVATION
In clinical practice anesthesiologist have to observe and control a huge amount of hemodynamic and respiratory variables as well as clinical signs of adequate hypnosis and analgesia. In neuro-, thoracic-and abdominal surgery a continuous neuromuscular block is needed to guarantee optimal surgical conditions. After the application of neuromuscular drugs an artificial ventilation is essential. The control of artificial ventilation is also an important research topic in connection with the topic of 'Control in anesthesia' but shall not included into the following chapters. The remarks are restricted to liquid intravenously injected drugs.
More and more new short-acting drugs like mivacurium, propofol and remifentanil are inherent parts in modern anesthesia practice. This needs a continuous mode for drug application and implies the use of automatic control. Precondition for designing a closed loop control system is an actuator which allows to control the current infusion rate. With the development of remote controllable infusion pumps one barrier on the way to design a control system was vaulted.
The majority of the used drugs operate not only straight forward to the desired effect. For example the hypnotic drug propofol effects not only on hypnosis level but increase also the analgesia level. The same behavior exists in the opposite way for the analgetic drug remifentanil. Remifentanil has the main focus to increase the analgesia level but in a sideway it increases also the hypnosis.
Because of the cross-actions between the drugs the anesthetist can adjust the desired level of hypnosis and analgesia with different amount of both drugs. From the control engineering point of view is the adequate anesthesia a multiple-input -multiple-output problem (MIMO).
In the daily routine work the anesthetists calculate the necessary drug amount with the help of dose regimes given by the drug manufacturer, mostly in relation to the patient body weight. Physicians with more experiences correlate dose regime with observations of the general patient behavior. Fig. 1 shows the measurement of the muscle response of 50 patient, measured in our clinic, which received all the same body weight dependence infusion of muscle relaxation drug. The dark black line visualize the desired effect and was calculated as mean value over the 50 patients. The figure pointed out the individual variance of the drug response. As conclusion a individual calculation of the drug with a closed-loop control system can avoid such over and under doses effect how to see in Fig. 1 . In the following chapters the steps from measurement to controller design are drafted. Section II described the problem of measurement the state of relaxation, hypnosis and analgesia. The effect from the drug to the human body should be modeled for the off-line controller design. Different strategies for modeling are discussed in section III. Different groups worldwide are working more or less continuously on the field of controller design for drug delivery in anesthesia. In section IV the development of several controller is reflected. The last section, section V, gives a summary and publishes the vision of the authors.
II. MEASUREMENT THE STATE OF RELAXATION, HYPNOSIS AND ANALGESIA

A. Measurement of the muscle relaxation
As discussed in section I one of the main concern of the anesthetist in the operating theatre is the monitoring and control of muscle relaxation. The evoked muscle response after supramaximal stimulation of its motoric nerve (e.g. ulnaris nerve -adductor pollicis muscle) can be registered by electromyography (EMG), mechanomyography (MMG) or acceleromyography (AMG). Because mechanomyography as gold standard of neuromuscular monitoring is unapplicable in routine clinical practice and only used for scientific purposes AMG is now generally accepted for measuring muscle force. Most of the research groups working at the field of control the muscle relaxation prefer the EMG as integrated sum muscle potential because it is easy to apply and less vulnerable to mechanical interferences. Fig. 2 shows the signal, recorded by the measurement device, wich was developed in our group to observe the signal quality every time. Other groups try to use commercial measurement technique for registration the neuromuscular blockade. For example the research group in Sheffield used the "Relaxograph NMT 100" (Fa.Datex) [1] or the group in Bern used the "NMT-module" for the AS3-monitor (Fa.Datex) [2] . There exist no much more commercial devices for the registration of the neuromuscular blockade. The existing devices transmit only a number and no or only a few of signal-quality information.
The usual method to record the degree of muscle relaxation is based on a train-of-four (TOF) stimulation of e peripheral nerve and the respective measurement of the muscle response. Fig. 3 shows the stimulation patter.
For the TOF-stimulation a series of four stimulations in an interval of 500ms, each stimulus 200 − 300µs long, is applied. A "supramaximal" stimulation current is used to stimulate all fibers of the nerve, typically the "nervus ulnaris" [3] . The period of stimulation is limited to 10 − 12s because of the necessary physiological regeneration of the muscles. Since in a lot of applications the set point of 90% neuromuscular blockade is prescribed, other stimulation patterns like train-of-four (TOF) are with regard to the twitch suppression not more effective than the T 1-stimulation. By using the single-twitch stimulation mode (one twitch every 12 sec.) a control value (T1/T0) is needed prior to the application of the muscle relaxant. The T1 value decreases after an initial bolus injection and the neuromuscular block increases.
B. Measurement of the depth of hypnosis
The anesthetist use different variables for estimating the depth of hypnosis, some of them like tearing and sweating are not measurable. However, the automation of the control of depth of hypnosis needs measurable outputs.
Measuring depth of hypnosis is often discussed and no final answer can be given. Many researcher and companies [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] looking for the best parameters, which can describe the level of hypnosis. Depth of hypnosis is expected to be reflected in the electroencephalogram (EEG). Different algorithms are known for estimation of residuals as indicator for the depth of hypnosis from the raw EEG. The main disadvantage of the EEG measurement is the variance with different anesthetic agents.
A group of measures are based on the power spectrum. The complexity of the raw EEG is decreasing with an increasing depth of hypnosis. The spectral edge frequency 95% (SEF 95) determines the maximum frequency for 95% of the signal power. The median frequency means the 50% of the power spectrum. The edge frequencies are decreasing with increasing depth of hypnosis. The correlation of the spectral edge frequencies is not closed, the use of the SEF as valid measurement for the depth of anesthesia is contentious [14] .
The bispectral index (BIS) becomes very popular in the last years and has been validated in large studies. The precise algorithm is proprietary and has not been published. The algorithm combines the power spectrum and bispectrum with a burst suppression analysis. The BIS describes a complex EEG pattern within a simple variable. A good correlation of the BIS with the plasma concentration of Sevoflurane is described in [14] . A different time delay of the BIS value in contrast to other measurement methods is observable depending on the software version inside the BIS-Monitor (Fa:Aspect Medical) and the filter adjustment.
Another hypnosis-level-index is powered by the Narkotrend-Monitor (Fa: MH-Hanover). A comparison study showed the differences between both parameters [20] . The BIS-Monitor is because of the powerful evaluation studies more accepted. He subdivided the level of hypnosis in scale from 0 − 100. 0 described an isoelectrical EEG and 100 a wake patient. The developer of the algorithm advise for general anesthesia a BIS-Index between 40 and 60.
Another measurement procedure is the measurement of the response of the EEG on stimulation. The evoked potentials reflects the subjective clinical signs that anesthesists use. The evoked potentials are an indicator for the responsiveness of the central nervous system (CNS). Auditory evoked potentials (AEP) are used in different applications [21] , [22] . A new idea to derive parameters from EEG was researched in Canada. With the help of wavelet analysis a more robust parameter should be founded [23] . The clinical evaluation with a big study is prepared.
C. Measurement of the level of analgesia
The main problem of measuring the analgesia level is the loss of parameters which describe the actual status. Therefore the notion of measuring the antinociceptive effect will used [4] . A surgical trauma is usually accompanied with strong sympathetic and parasympathetic activity, like heart rate and blood pressure changes, sweating, etc. A combination, for example of changes in heart rate and changes in blood pressure is used in [22] , [24] to identify a inadequate analgesia level.
The measurement of the Heart Rate Variability (HRV) is a rather new technique to quantify the analgesia and could be, in combination with a second parameter derived from vital function [25] , [26] , a valid parameter for a analgesia controller.
III. MODELING
For the controller design it's much more favorable and desirable to use a model description. After translation into the world of anesthesia we are looking for a description of the dose-effect-relationship. There are two ways to describe the effect of the drugs in the human body.
A. Compartmental Models
The pharmacology is the science of drug distribution and elimination and effect. The most popular kind to model the drug distribution and elimination are the pharmacikinetic-pharmacodynamic (PKPD) models. Pharmacokinetics means the dynamic process of drug distribution in the body and pharmacodynamics means the description of the effect of the drug on the body [27] . Compartmental models are formulated on the basis of the minimal number of compartments that adequately fits observed data [2] . Compartmental models are subdivided into simple, catenary and mamillary models. The simple model is a special case of the other types. The models consist of central and peripheral components. The most common structure is the mamillary model. The peripheral compartments are linked via micro rate constants to the central compartment.
The compartments of the catenary model are arranged in a chain. A typical structure of the mamillary model is shown in Fig. 4 . The pharmacokinetics is described by one central compartment, number 1 in Fig. 4 , and one or more peripheral compartments, number 2. The peripheral compartments are linked to the central compartment via micro rate constants (k xy ). The drug distribution is described by the micro rate constants and by the elimination time constant (k 10 ). An additional dynamic compartment described the pharmacodyamics [28] , [29] . The pharmacodynamics are described by an additional dynamic compartment, the effectsite compartment (E) and a static dose-effect nonlinearity, the E max -model [30] , [31] . The advantage of these models is the relatively small number of adjustable parameters. The concentration of the drug elimination is the main disadvantage of these models. The initial transport and the distribution are only fragmentary implemented.
B. Physiological Modeling
The physiological based models try to eliminate the disadvantages. The physiological models are subdivided into flow based and recirculatory based models [27] , [32] .
The first subgroup concentrates on the distribution of the drug into different organs or organ groups and consist of many body compartments [2] . Fig. 5(a) shows the idea of the model in a scheme. In Fig. 5(a) i R characterize the drug infusion rate. The drug is been injected into the venous blood pool, with corresponding compartmental concentration c V . Other meanings are compartment concentration in lung c L , arterial blood pool c A , myocard c 1 , brain gray matter c 2 , brain white matter c 3 , well perfused organs c 4 , poor perfused organs c 6 , skeletal muscle c 7 , fat c 8 , skin shunt c 9 , lung shunt ls and the corresponding blood flow q i . Fig. 5(b) gives the idea of one compartment. The compartment is divided into blood and a tissue part with corresponding volumes (V i,b and V i,t ) and coefficients (λ i,b and λ i,t ). q i is the blood flow through the compartment, k i described the elimination.
The advantage of the physiological based models is the more detailed description of the drug movement in the human body and the disadvantage is the big amount of parameters. Some simplifications are necessary before the models can use in routine work [2] .
IV. CONTROLLER
From the beginning of the eighties physicians and engineers trying to develop closed-loop controller for drug delivery. One of the first was Koivo [33] . He developed a blood-pressure control system and tested it on dogs. Over the years a lot of other controller for hemodynamic parameters were developed, but not with the focus of anesthesia conditions [34] , [35] , [36] . Only few works used blood pressure controller under surgical conditions [37] , [38] .
Much more research power was invested in the development of closed-loop controller which are direct connected with on of the main parts of anesthesia, relaxation, hypnosis or analgesia.
Because of the well known models for relaxation drug effects a lot of different model-free (e.g.. PID) or modelbased (e.g. GPC) controller were developed and tested in the operating room [39] , [40] , [41] , [42] , [43] , [44] , [2] , [45] , [46] .
The design of controller for the hypnosis level is because of the non sufficient measurement technique and cross reaction of the hypnotic drug with other drugs much more difficult. The controller structures range from simple PI-and PID-over model-based to Fuzzy-controller [47] , [48] , [49] , [50] , [51] , [9] , [20] .
The cross reactions of the hypnotic and analgetic drugs, described in a previous section were researched during the last years [52] , [53] , [54] , [55] , [56] .
New controller strategies try to handle both variables hypnosis and analgesia at the same time as MIMOcontroller [22] , [24] . Fig. 6 shows an example for a possible research equipment, how it could be helpful for the controller development. The interface between technique and anesthetist is important in the same way like the save collection of measurement data.
As example some more details from the "Rostocker assistent system for anaesthesia control (RAN)" will be given in the following rows. Fig. 7 shows the structure of the multiple-input multiple-output system for the control of neuromuscular blockade and depth of hypnosis used in the "Rostocker assistent system for anesthesia control (RAN)".
In the current configuration neuromuscular monitoring is registered electromyographically using single twitch stimuli with a sampling period of 12s. The original emgresponses is visualized and registered online. The setpoint 6 . Components of the research equipment for the development of the "Rostocker assistent system for anesthesia control (RAN)" [20] , [45] .
for the neuromuscular blockade is 90% (T 1 = 10% of the signal before drug administration). An adaptive Generalized Predictive Controller (aGPC) is used for the control of neuromuscular block.
In the RAN the depth of hypnosis is measured via bispectral index (BIS-XP-monitor). A Fuzzy-PD+I (P=proportional-, D=differential-, I=integral-part) controller calculates the amount of hypnotic drug propofol witch was necessary to minimize the error between the actual measured BIS-value and the BIS-setpoint of 40 every 5 seconds. Controller details are published in [45] and [57] . Fig. 8 shows on controlled example. The setpoint for the neuromuscular blockade (T 1 = 10%) was illustrated together with the measurement signal in the upper figure. Below the measurement signal the infusionrate of mivacurium as neuromuscular drug calculated from the adaptive Generalized predictive controller (aGPC) was plotted. The both lower figures show the measured BIS-index and the infusionrate for the hypnotic drug propofol.
Current research work is concentrated at the development of an automatic controller for controlling the analgesia level and to replace the anesthetist as "analgesiacontroller". 
V. SUMMARY
The discussion about the automation in anesthesia is as old like the first developments [58] , [59] . The paper tried to explain in a very short way the market and the potential for modeling and control in anesthesia, especially in the field of automatic drug delivery. The most important thing was to transport the idea and the vision: that automation in anesthesia can assist and not replace the anesthetists. New visualization system can assist the medical staff [60] .
Furthermore constant neuromuscular block precisely adjusted to the individual patient leads to better intraoperative conditions, reduces drug consumption, shorten the postoperative recovery period and finally save costs. Monitoring the depth of hypnosis reduce the probability of awareness and drug overdoses. Therefore "The International Task Force on Anesthesia Safety" expanded in 1993 the term of anesthesia monitoring. The monitoring of hypnosis and neuromuscular function are described as essentials of adequate intraoperative monitoring [61] .
The vision of the most described research works is the design of an assistant system for anesthesia work similar to the autopilot in the airplane.
